Literature DB >> 2060554

Response to furosemide during dehydration with and without naproxen pretreatment of kidney donors and renal transplant recipients.

P A Sjöström1, B G Odlind, M Hammarlund-Udenaes.   

Abstract

The response to 40 mg furosemide p.o. in 6 healthy kidney donors and 6 renal transplant recipients with and without naproxen pretreatment has been studied. No volume replacement was given in order to study the development of tolerance. The subjects showed an average dehydration of 1.5 kg.6 h-1. While mean creatinine clearance was equal in patients and donors (76 vs 80 ml/min), renal furosemide clearance was significantly lower in the patients (47 vs 81 ml min; P less than 0.05). The patients also excreted a smaller fraction of the dose in the urine (5.7 vs 7.8 mg/6 h; P less than 0.05). As the overall renal sensitivity was similar in the two groups, the natriuretic response was correspondingly smaller in transplant recipients as compared to donors. Within the observation period of 6 h after dosing, acute tolerance developed in the donors and in 4 of the 6 patients, as shown by clockwise hysteresis in the dose (urine furosemide excretion rate)-response (natriuresis) curves. Pretreatment with naproxen reduced renal sensitivity to furosemide (right shift of the dose response curve) in all the donors but in only 2 of the patients. In both groups acute tolerance was less pronounced after naproxen, which may indicate involvement of the prostaglandin system in the development of acute tolerance. The results may also indicate regeneration of sympathetic nerves with functional capacity in at least some renal transplants, or that other mechanisms of salt regulation compensate for loss of sympathetic nerve activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060554     DOI: 10.1007/bf00315197

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney.

Authors:  S Hall; M Rowland
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

2.  On the mechanism of acute tolerance to furosemide diuresis.

Authors:  P A Sjöström; B G Odlind; B A Beermann; M Hammarlund-Udenaes
Journal:  Scand J Urol Nephrol       Date:  1988

3.  The adaptive role of renal prostaglandin production: current clinical problems and future clinical horizons.

Authors:  E T Zawada
Journal:  Nephron       Date:  1984       Impact factor: 2.847

4.  Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man.

Authors:  P Chennavasin; R Seiwell; D C Brater
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

5.  Excretory function after renal denervation and administration of diuretics to unanesthetized dogs.

Authors:  R A Girchev; N D Natcheff
Journal:  Biomed Biochim Acta       Date:  1988

6.  Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis.

Authors:  M M Hammarlund; L K Paalzow; B Odlind
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  The role of renal nerves and prostaglandins in control of renal hemodynamics and plasma renin activity during hypotensive hemorrhage in the dog.

Authors:  W L Henrich; R J Anderson; A S Berns; K M McDonald; P J Paulsen; T Berl; R W Schrier
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Abnormal renal sodium excretion in the nephrotic syndrome after furosemide: relation to glomerular filtration rate.

Authors:  H Danielsen; E B Pedersen; M Madsen; T Jensen
Journal:  Acta Med Scand       Date:  1985

9.  Implications of intraindividual variability in bioavailability studies of furosemide.

Authors:  A Grahnén; M Hammarlund; T Lundqvist
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men.

Authors:  D C Brater; S Anderson; B Baird; W B Campbell
Journal:  Kidney Int       Date:  1985-01       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.